PDB Short entry for 2WFD HEADER LIGASE 03-APR-09 2WFD TITLE STRUCTURE OF THE HUMAN CYTOSOLIC LEUCYL-TRNA SYNTHETASE TITLE 2 EDITING DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: LEUCYL-TRNA SYNTHETASE, CYTOPLASMIC; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: EDITING OR CP1 DOMAIN, RESIDUES 260-509; COMPND 5 SYNONYM: LEUCINE--TRNA LIGASE, LEURS; COMPND 6 EC: 6.1.1.4; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PPROEX HTB KEYWDS AMINOACYL-TRNA SYNTHETASE, PHOSPHOPROTEIN, EDITING DOMAIN, KEYWDS 2 NUCLEOTIDE-BINDING, HYDROLYSIS OF MIS-CHARGED TRNAS, KEYWDS 3 PROTEIN BIOSYNTHESIS, LEUCYL-TRNA SYNTHETASE, HUMAN, KEYWDS 4 LIGASE, CYTOPLASM, ATP-BINDING, POLYMORPHISM EXPDTA X-RAY DIFFRACTION AUTHOR E.SEIRADAKE,W.MAO,V.HERNANDEZ,S.J.BAKER,J.J.PLATTNER, AUTHOR 2 M.R.K.ALLEY,S.CUSACK REVDAT 2 23-JUN-09 2WFD 1 JRNL REVDAT 1 19-MAY-09 2WFD 0 JRNL AUTH E.SEIRADAKE,W.MAO,V.HERNANDEZ,S.J.BAKER, JRNL AUTH 2 J.J.PLATTNER,M.R.K.ALLEY,S.CUSACK JRNL TITL CRYSTAL STRUCTURES OF THE HUMAN AND FUNGAL JRNL TITL 2 CYTOSOLIC LEUCYL-TRNA SYNTHETASE EDITING DOMAINS: JRNL TITL 3 A STRUCTURAL BASIS FOR THE RATIONAL DESIGN OF JRNL TITL 4 ANTIFUNGAL BENZOXABOROLES. JRNL REF J.MOL.BIOL. V. 390 196 2009 JRNL REFN ISSN 0022-2836 JRNL PMID 19426743 JRNL DOI 10.1016/J.JMB.2009.04.073 REMARK 2 REMARK 2 RESOLUTION. 3.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0070 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 11198 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 612 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.33 REMARK 3 REFLECTION IN BIN (WORKING SET) : 812 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.3000 REMARK 3 BIN FREE R VALUE SET COUNT : 46 REMARK 3 BIN FREE R VALUE : 0.2500 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3922 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.471 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.378 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 50.954 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.920 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.894 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3990 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2788 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5380 ; 1.318 ; 2.004 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6886 ; 0.852 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 502 ; 6.816 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 152 ;43.273 ;25.526 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 770 ;17.806 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;17.321 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 614 ; 0.069 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4318 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 710 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2508 ; 0.336 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1018 ; 0.043 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4064 ; 0.650 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1482 ; 0.943 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1316 ; 1.571 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 2 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 258 A 401 1 REMARK 3 1 B 258 B 401 1 REMARK 3 2 A 425 A 509 1 REMARK 3 2 B 425 B 509 1 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 TIGHT POSITIONAL 1 A (A): 3019 ; 0.03 ; 0.05 REMARK 3 TIGHT POSITIONAL 1 B (A): 3019 ; 0.03 ; 0.05 REMARK 3 TIGHT THERMAL 1 A (A**2): 3019 ; 0.88 ; 5.00 REMARK 3 TIGHT THERMAL 1 B (A**2): 3019 ; 0.88 ; 5.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B FACTORS REMARK 3 ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U FACTORS REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 258 A 509 REMARK 3 ORIGIN FOR THE GROUP (A): 25.2490 -37.7950 -15.7780 REMARK 3 T TENSOR REMARK 3 T11: -0.2567 T22: -0.0849 REMARK 3 T33: -0.2320 T12: -0.0346 REMARK 3 T13: 0.0132 T23: -0.0633 REMARK 3 L TENSOR REMARK 3 L11: 4.2893 L22: 1.6841 REMARK 3 L33: 1.6987 L12: 2.3531 REMARK 3 L13: 0.2890 L23: 0.0995 REMARK 3 S TENSOR REMARK 3 S11: 0.0355 S12: -0.2551 S13: 0.1820 REMARK 3 S21: 0.1789 S22: -0.0285 S23: 0.0712 REMARK 3 S31: -0.1952 S32: -0.1560 S33: -0.0069 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 258 B 509 REMARK 3 ORIGIN FOR THE GROUP (A): 27.4800 -37.8330 -48.7140 REMARK 3 T TENSOR REMARK 3 T11: -0.2598 T22: -0.0426 REMARK 3 T33: -0.1828 T12: -0.1087 REMARK 3 T13: 0.0193 T23: -0.0400 REMARK 3 L TENSOR REMARK 3 L11: 3.9546 L22: 1.7456 REMARK 3 L33: 4.1614 L12: 1.5832 REMARK 3 L13: -0.9927 L23: -0.1080 REMARK 3 S TENSOR REMARK 3 S11: -0.0754 S12: 0.5118 S13: 0.0413 REMARK 3 S21: -0.1161 S22: 0.0261 S23: 0.2995 REMARK 3 S31: 0.2456 S32: -1.0905 S33: 0.0493 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. U VALUES RESIDUAL ONLY REMARK 4 REMARK 4 2WFD COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-APR-09. REMARK 100 THE PDBE ID CODE IS EBI-39386. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15008 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.00 REMARK 200 RESOLUTION RANGE LOW (A) : 30.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.12 REMARK 200 R MERGE (I) : 0.15 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.46 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.16 REMARK 200 R MERGE FOR SHELL (I) : 0.66 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.98 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELXD SHARP REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.2 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM CITRATE TRIBASIC REMARK 280 DIHYDRATE PH 8.3, 20% W/V POLYETHYLENE GLYCOL 3350 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 99.21333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 49.60667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 74.41000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 24.80333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 124.01667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.93 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MSE A 259 -161.32 65.10 REMARK 500 MSE A 299 2.40 -69.61 REMARK 500 ASN A 304 -164.17 -173.30 REMARK 500 CYS A 326 -172.89 -171.40 REMARK 500 LEU A 366 -54.74 69.23 REMARK 500 ASP A 383 -80.31 -69.01 REMARK 500 VAL A 423 -56.10 -130.99 REMARK 500 LYS A 450 64.59 64.77 REMARK 500 ASN A 455 31.92 -86.85 REMARK 500 ASP A 456 54.62 -105.26 REMARK 500 PHE A 482 69.76 -167.39 REMARK 500 MSE B 259 -161.51 67.27 REMARK 500 MSE B 299 1.37 -68.85 REMARK 500 ASN B 304 -165.17 -172.13 REMARK 500 CYS B 326 -174.25 -172.08 REMARK 500 LEU B 366 -56.19 68.24 REMARK 500 ASP B 383 -74.99 -69.67 REMARK 500 ALA B 402 -71.88 -61.69 REMARK 500 ASP B 421 -44.45 -17.22 REMARK 500 VAL B 423 -66.97 -142.26 REMARK 500 ASN B 455 30.27 -87.68 REMARK 500 ASP B 456 57.76 -104.79 REMARK 500 PHE B 482 71.07 -165.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 SELENOMETHIONINE (MSE): PROTEIN WAS SELENOMETHIONINE REMARK 600 LABELLED REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 999 REMARK 999 SEQUENCE REMARK 999 EXTRA ALA-MET AT N-TERMINUS FROM CLONING. DBREF 2WFD A 258 259 PDB 2WFD 2WFD 258 259 DBREF 2WFD A 260 509 UNP Q9P2J5 SYLC_HUMAN 260 509 DBREF 2WFD B 258 259 PDB 2WFD 2WFD 258 259 DBREF 2WFD B 260 509 UNP Q9P2J5 SYLC_HUMAN 260 509 SEQRES 1 A 252 ALA MSE GLY PRO GLN GLU TYR THR LEU LEU LYS LEU LYS SEQRES 2 A 252 VAL LEU GLU PRO TYR PRO SER LYS LEU SER GLY LEU LYS SEQRES 3 A 252 GLY LYS ASN ILE PHE LEU VAL ALA ALA THR LEU ARG PRO SEQRES 4 A 252 GLU THR MSE PHE GLY GLN THR ASN CYS TRP VAL ARG PRO SEQRES 5 A 252 ASP MSE LYS TYR ILE GLY PHE GLU THR VAL ASN GLY ASP SEQRES 6 A 252 ILE PHE ILE CYS THR GLN LYS ALA ALA ARG ASN MSE SER SEQRES 7 A 252 TYR GLN GLY PHE THR LYS ASP ASN GLY VAL VAL PRO VAL SEQRES 8 A 252 VAL LYS GLU LEU MSE GLY GLU GLU ILE LEU GLY ALA SER SEQRES 9 A 252 LEU SER ALA PRO LEU THR SER TYR LYS VAL ILE TYR VAL SEQRES 10 A 252 LEU PRO MSE LEU THR ILE LYS GLU ASP LYS GLY THR GLY SEQRES 11 A 252 VAL VAL THR SER VAL PRO SER ASP SER PRO ASP ASP ILE SEQRES 12 A 252 ALA ALA LEU ARG ASP LEU LYS LYS LYS GLN ALA LEU ARG SEQRES 13 A 252 ALA LYS TYR GLY ILE ARG ASP ASP MSE VAL LEU PRO PHE SEQRES 14 A 252 GLU PRO VAL PRO VAL ILE GLU ILE PRO GLY PHE GLY ASN SEQRES 15 A 252 LEU SER ALA VAL THR ILE CYS ASP GLU LEU LYS ILE GLN SEQRES 16 A 252 SER GLN ASN ASP ARG GLU LYS LEU ALA GLU ALA LYS GLU SEQRES 17 A 252 LYS ILE TYR LEU LYS GLY PHE TYR GLU GLY ILE MSE LEU SEQRES 18 A 252 VAL ASP GLY PHE LYS GLY GLN LYS VAL GLN ASP VAL LYS SEQRES 19 A 252 LYS THR ILE GLN LYS LYS MSE ILE ASP ALA GLY ASP ALA SEQRES 20 A 252 LEU ILE TYR MSE GLU SEQRES 1 B 252 ALA MSE GLY PRO GLN GLU TYR THR LEU LEU LYS LEU LYS SEQRES 2 B 252 VAL LEU GLU PRO TYR PRO SER LYS LEU SER GLY LEU LYS SEQRES 3 B 252 GLY LYS ASN ILE PHE LEU VAL ALA ALA THR LEU ARG PRO SEQRES 4 B 252 GLU THR MSE PHE GLY GLN THR ASN CYS TRP VAL ARG PRO SEQRES 5 B 252 ASP MSE LYS TYR ILE GLY PHE GLU THR VAL ASN GLY ASP SEQRES 6 B 252 ILE PHE ILE CYS THR GLN LYS ALA ALA ARG ASN MSE SER SEQRES 7 B 252 TYR GLN GLY PHE THR LYS ASP ASN GLY VAL VAL PRO VAL SEQRES 8 B 252 VAL LYS GLU LEU MSE GLY GLU GLU ILE LEU GLY ALA SER SEQRES 9 B 252 LEU SER ALA PRO LEU THR SER TYR LYS VAL ILE TYR VAL SEQRES 10 B 252 LEU PRO MSE LEU THR ILE LYS GLU ASP LYS GLY THR GLY SEQRES 11 B 252 VAL VAL THR SER VAL PRO SER ASP SER PRO ASP ASP ILE SEQRES 12 B 252 ALA ALA LEU ARG ASP LEU LYS LYS LYS GLN ALA LEU ARG SEQRES 13 B 252 ALA LYS TYR GLY ILE ARG ASP ASP MSE VAL LEU PRO PHE SEQRES 14 B 252 GLU PRO VAL PRO VAL ILE GLU ILE PRO GLY PHE GLY ASN SEQRES 15 B 252 LEU SER ALA VAL THR ILE CYS ASP GLU LEU LYS ILE GLN SEQRES 16 B 252 SER GLN ASN ASP ARG GLU LYS LEU ALA GLU ALA LYS GLU SEQRES 17 B 252 LYS ILE TYR LEU LYS GLY PHE TYR GLU GLY ILE MSE LEU SEQRES 18 B 252 VAL ASP GLY PHE LYS GLY GLN LYS VAL GLN ASP VAL LYS SEQRES 19 B 252 LYS THR ILE GLN LYS LYS MSE ILE ASP ALA GLY ASP ALA SEQRES 20 B 252 LEU ILE TYR MSE GLU MODRES 2WFD MSE A 259 MET SELENOMETHIONINE MODRES 2WFD MSE A 299 MET SELENOMETHIONINE MODRES 2WFD MSE A 311 MET SELENOMETHIONINE MODRES 2WFD MSE A 334 MET SELENOMETHIONINE MODRES 2WFD MSE A 353 MET SELENOMETHIONINE MODRES 2WFD MSE A 377 MET SELENOMETHIONINE MODRES 2WFD MSE A 422 MET SELENOMETHIONINE MODRES 2WFD MSE A 477 MET SELENOMETHIONINE MODRES 2WFD MSE A 498 MET SELENOMETHIONINE MODRES 2WFD MSE A 508 MET SELENOMETHIONINE MODRES 2WFD MSE B 259 MET SELENOMETHIONINE MODRES 2WFD MSE B 299 MET SELENOMETHIONINE MODRES 2WFD MSE B 311 MET SELENOMETHIONINE MODRES 2WFD MSE B 334 MET SELENOMETHIONINE MODRES 2WFD MSE B 353 MET SELENOMETHIONINE MODRES 2WFD MSE B 377 MET SELENOMETHIONINE MODRES 2WFD MSE B 422 MET SELENOMETHIONINE MODRES 2WFD MSE B 477 MET SELENOMETHIONINE MODRES 2WFD MSE B 498 MET SELENOMETHIONINE MODRES 2WFD MSE B 508 MET SELENOMETHIONINE HET MSE A 259 8 HET MSE A 299 8 HET MSE A 311 8 HET MSE A 334 8 HET MSE A 353 8 HET MSE A 377 8 HET MSE A 422 8 HET MSE A 477 8 HET MSE A 498 8 HET MSE A 508 8 HET MSE B 259 8 HET MSE B 299 8 HET MSE B 311 8 HET MSE B 334 8 HET MSE B 353 8 HET MSE B 377 8 HET MSE B 422 8 HET MSE B 477 8 HET MSE B 498 8 HET MSE B 508 8 HETNAM MSE SELENOMETHIONINE FORMUL 3 MSE 20(C5 H11 N O2 SE) HELIX 1 1 PRO A 276 LYS A 283 5 8 HELIX 2 2 ARG A 295 MSE A 299 5 5 HELIX 3 3 THR A 327 MSE A 334 1 8 HELIX 4 4 SER A 396 LYS A 409 1 14 HELIX 5 5 GLN A 410 LYS A 415 1 6 HELIX 6 6 LEU A 440 LEU A 449 1 10 HELIX 7 7 ASP A 456 GLY A 475 1 20 HELIX 8 8 LYS A 486 MSE A 498 1 13 HELIX 9 9 PRO B 276 LYS B 283 5 8 HELIX 10 10 ARG B 295 MSE B 299 5 5 HELIX 11 11 THR B 327 MSE B 334 1 8 HELIX 12 12 SER B 396 LYS B 409 1 14 HELIX 13 13 LYS B 409 ALA B 414 1 6 HELIX 14 14 LYS B 415 GLY B 417 5 3 HELIX 15 15 LEU B 440 LEU B 449 1 10 HELIX 16 16 ASP B 456 GLY B 475 1 20 HELIX 17 17 LYS B 486 MSE B 498 1 13 SHEET 1 AA 6 VAL A 348 GLU A 351 0 SHEET 2 AA 6 ILE A 314 GLU A 317 -1 O GLY A 315 N VAL A 349 SHEET 3 AA 6 ILE A 323 CYS A 326 -1 O PHE A 324 N PHE A 316 SHEET 4 AA 6 ILE A 287 THR A 293 1 O PHE A 288 N ILE A 325 SHEET 5 AA 6 TYR A 264 LEU A 272 -1 O THR A 265 N THR A 293 SHEET 6 AA 6 ALA A 504 TYR A 507 -1 O LEU A 505 N LEU A 266 SHEET 1 AB 9 VAL A 348 GLU A 351 0 SHEET 2 AB 9 ILE A 314 GLU A 317 -1 O GLY A 315 N VAL A 349 SHEET 3 AB 9 ILE A 323 CYS A 326 -1 O PHE A 324 N PHE A 316 SHEET 4 AB 9 ILE A 287 THR A 293 1 O PHE A 288 N ILE A 325 SHEET 5 AB 9 TYR A 264 LEU A 272 -1 O THR A 265 N THR A 293 SHEET 6 AB 9 SER A 361 SER A 363 -1 O SER A 361 N LEU A 272 SHEET 7 AB 9 ILE A 372 PRO A 376 -1 O ILE A 372 N LEU A 362 SHEET 8 AB 9 ASN A 304 VAL A 307 1 O CYS A 305 N LEU A 375 SHEET 9 AB 9 VAL A 389 SER A 391 -1 O VAL A 389 N TRP A 306 SHEET 1 BA 6 VAL B 348 GLU B 351 0 SHEET 2 BA 6 ILE B 314 GLU B 317 -1 O GLY B 315 N VAL B 349 SHEET 3 BA 6 ILE B 323 CYS B 326 -1 O PHE B 324 N PHE B 316 SHEET 4 BA 6 ILE B 287 THR B 293 1 O PHE B 288 N ILE B 325 SHEET 5 BA 6 TYR B 264 LEU B 272 -1 O THR B 265 N THR B 293 SHEET 6 BA 6 ALA B 504 TYR B 507 -1 O LEU B 505 N LEU B 266 SHEET 1 BB 9 VAL B 348 GLU B 351 0 SHEET 2 BB 9 ILE B 314 GLU B 317 -1 O GLY B 315 N VAL B 349 SHEET 3 BB 9 ILE B 323 CYS B 326 -1 O PHE B 324 N PHE B 316 SHEET 4 BB 9 ILE B 287 THR B 293 1 O PHE B 288 N ILE B 325 SHEET 5 BB 9 TYR B 264 LEU B 272 -1 O THR B 265 N THR B 293 SHEET 6 BB 9 SER B 361 SER B 363 -1 O SER B 361 N LEU B 272 SHEET 7 BB 9 ILE B 372 PRO B 376 -1 O ILE B 372 N LEU B 362 SHEET 8 BB 9 ASN B 304 VAL B 307 1 O CYS B 305 N LEU B 375 SHEET 9 BB 9 VAL B 389 SER B 391 -1 O VAL B 389 N TRP B 306 LINK C ALA A 258 N MSE A 259 1555 1555 1.35 LINK C MSE A 259 N GLY A 260 1555 1555 1.33 LINK C THR A 298 N MSE A 299 1555 1555 1.33 LINK C MSE A 299 N PHE A 300 1555 1555 1.33 LINK C ASP A 310 N MSE A 311 1555 1555 1.33 LINK C MSE A 311 N LYS A 312 1555 1555 1.33 LINK C ASN A 333 N MSE A 334 1555 1555 1.33 LINK C MSE A 334 N SER A 335 1555 1555 1.33 LINK C LEU A 352 N MSE A 353 1555 1555 1.33 LINK C MSE A 353 N GLY A 354 1555 1555 1.32 LINK C PRO A 376 N MSE A 377 1555 1555 1.33 LINK C MSE A 377 N LEU A 378 1555 1555 1.32 LINK C ASP A 421 N MSE A 422 1555 1555 1.34 LINK C MSE A 422 N VAL A 423 1555 1555 1.33 LINK C ILE A 476 N MSE A 477 1555 1555 1.33 LINK C MSE A 477 N LEU A 478 1555 1555 1.33 LINK C LYS A 497 N MSE A 498 1555 1555 1.32 LINK C MSE A 498 N ILE A 499 1555 1555 1.33 LINK C TYR A 507 N MSE A 508 1555 1555 1.33 LINK C MSE A 508 N GLU A 509 1555 1555 1.33 LINK C ALA B 258 N MSE B 259 1555 1555 1.34 LINK C MSE B 259 N GLY B 260 1555 1555 1.33 LINK C THR B 298 N MSE B 299 1555 1555 1.33 LINK C MSE B 299 N PHE B 300 1555 1555 1.33 LINK C ASP B 310 N MSE B 311 1555 1555 1.32 LINK C MSE B 311 N LYS B 312 1555 1555 1.33 LINK C ASN B 333 N MSE B 334 1555 1555 1.33 LINK C MSE B 334 N SER B 335 1555 1555 1.33 LINK C LEU B 352 N MSE B 353 1555 1555 1.33 LINK C MSE B 353 N GLY B 354 1555 1555 1.32 LINK C PRO B 376 N MSE B 377 1555 1555 1.34 LINK C MSE B 377 N LEU B 378 1555 1555 1.33 LINK C ASP B 421 N MSE B 422 1555 1555 1.34 LINK C MSE B 422 N VAL B 423 1555 1555 1.33 LINK C ILE B 476 N MSE B 477 1555 1555 1.34 LINK C MSE B 477 N LEU B 478 1555 1555 1.33 LINK C LYS B 497 N MSE B 498 1555 1555 1.32 LINK C MSE B 498 N ILE B 499 1555 1555 1.33 LINK C TYR B 507 N MSE B 508 1555 1555 1.33 LINK C MSE B 508 N GLU B 509 1555 1555 1.33 CISPEP 1 GLY A 260 PRO A 261 0 12.92 CISPEP 2 GLU A 273 PRO A 274 0 10.38 CISPEP 3 GLY B 260 PRO B 261 0 11.69 CISPEP 4 GLU B 273 PRO B 274 0 10.82 CRYST1 94.540 94.540 148.820 90.00 90.00 120.00 P 65 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010578 0.006107 0.000000 0.00000 SCALE2 0.000000 0.012214 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006720 0.00000